Example: dental hygienist
Glosario de términos farmaceuticos / Glossary of ...
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies medicamentos con un uso médico bien establecido para el cual ningún producto de referencia está disponible en la UE. 2) Extensiones de la marca registrada a nivel nacional de medicamentos para los que una información armonizada del producto
Tags:
Information
Domain:
Source:
Link to this page:
Related documents
Access to medicines: making market forces serve the poor
www.who.intGlobal Strategy and Plan of Action on Public Health, Innovation and Intellectual ... pharmaceutical industry is a business, and a big one. Multinational pharmaceutical companies, ... would stimulate efforts to get prices down through policies such as tiered pricing, voluntary and compulsory licensing, pooled procurement, and bulk purchasing. ...
NEW DRUG LISTING & PRICING POLICIES IN CHINA
heatinformatics.compricing for “premium-priced” drugs, the majority of which are manufactured by multi-national companies (MNCs). For the first time, the Ministry has begun to consider pharmacoeconomic and budget-impact evidence in its decision-making, signaling the need for global companies to approach the Chinese market differently in future.
MEDICINES REIMBURSEMENT POLICIES IN EUROPE
www.euro.who.intauthorities included in the Pharmaceutical Pricing and Reimbursement Information (PPRI) network, a literature review, qualitative interviews with authorities and researchers in selected case study countries, and a cross-country analysis of the actual financial burden for patients.
ESG Performance Summary 2020 - GSK
www.gsk.comPublic policies available online 32 In our Annual Report: Stakeholder engagement ... Pricing Improve the health of millions of people each year by making ... Pharmaceutical business revenue (£m) 17,276 17,269 17,554 17,056 Vaccines business revenue (£m) ...
Economic Survey 2021-22
www.indiabudget.gov.in160 Global Inflation 161 Domestic Inflation 162 Current Trends in Inflation and its Drivers 188 Housing Prices 193 Pharmaceutical Pricing 194 Long Term Perspective for Management of Supply Side Factors 6 Sustainable Development and Climate Change 197 India’s Progress on Sustainable Development Goals 203 State of the Environment
MARKET INSIGHT Biopharmaceutical CDMOs Analysis
bourne-partners.comThe global biologics market is expected to account for ~30% of the entire pharma market by 2025 compared to 18.5% in 2015. In the ten year span from 2015 to 2025, the global biologics CDMO market is projected to grow at an average annual growth rate of 15.1% from $7.4b n to $30.3bn. 1
EFFECTS OF INNOVATION TYPES ON FIRM PERFORMANCE - …
research.sabanciuniv.edu1 EFFECTS OF INNOVATION TYPES ON FIRM PERFORMANCE Gurhan GUNDAY a, Gunduz ULUSOY a,*, Kemal KILIC a, Lutfihak ALPKAN b a Sabanci University, Faculty of Engineering and Natural Sciences, 34956 Orhanli-Tuzla, Istanbul, Turkey b Gebze Institute of Technology, Department of Management, No:101 41400 Cayirova Gebze-Kocaeli, Turkey E-mail addresses: …